[144] Camtek Ltd SEC Filing

Rhea-AI Filing Summary

Camtek Ltd (CAMT) submitted a Form 144 notice reporting a proposed sale of 21,321 ordinary shares through Oppenheimer & Co. Inc., with an aggregate market value of $1,844,906.13. The sale is scheduled approximately for 08/13/2025 and the shares are listed on Nasdaq. The form states the issuer has 45,449,306 shares outstanding, providing context for the transaction size.

The securities to be sold were acquired as restricted stock units from the issuer on 04/28/2021 (2,774 shares), 01/24/2022 (4,637 shares), and 01/16/2023 (13,910 shares), which together equal the 21,321 shares offered. The filing reports no securities sold in the past three months and includes the seller's standard representation that they are unaware of any undisclosed material adverse information; a trading-plan reference is noted but no plan adoption date is provided.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for 21,321 RSU shares with an aggregate value of $1.84M; appears to be a standard compliance filing.

The filing discloses a proposed sale routed through Oppenheimer & Co. Inc. and specifies acquisition details showing the shares originated from restricted stock unit grants on three dates in 2021, 2022 and 2023. The form confirms no sales in the prior three months, which limits immediate market-activity context. From an investor-disclosure perspective the document supplies required mechanics and avoids additional commentary; the material metrics provided are the share count, aggregate value, outstanding shares and approximate sale date.

Corporate Governance Expert

TL;DR: Filing adheres to Rule 144 disclosure norms and includes the seller's representation about nonpublic material information.

The notice explicitly states the seller represents they do not possess undisclosed material adverse information about the issuer and references the possibility of a Section 10b5-1 trading plan without supplying an adoption date. The acquisition details identify the securities as RSUs from the issuer, which is relevant for governance and insider-transaction records. The filing contains the essential broker, share amount, aggregate value and exchange details necessary for compliance and public record.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	21321	1844906.13	45449306	08/13/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	04/28/2021	Restricted Stock Units	From the Issuer			2774	04/28/2021	N/A
Ordinary	01/16/2023	Restricted Stock Units	From the Issuer			13910	01/16/2023	N/A
Ordinary	01/24/2022	Restricted Stock Units	From the Issuer			4637	01/24/2022	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)